BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 19178128)

  • 21. Bioavailability studies of nitrates in the dog.
    Hastings SG
    Arch Int Pharmacodyn Ther; 1973 May; 203(1):117-22. PubMed ID: 4199057
    [No Abstract]   [Full Text] [Related]  

  • 22. Pentaerythritol Tetranitrate Targeting Myocardial Reactive Oxygen Species Production Improves Left Ventricular Remodeling and Function in Rats With Ischemic Heart Failure.
    Fraccarollo D; Galuppo P; Neuser J; Bauersachs J; Widder JD
    Hypertension; 2015 Nov; 66(5):978-87. PubMed ID: 26351025
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chronic protection against ischemia and reperfusion-induced endothelial dysfunction during therapy with different organic nitrates.
    Lisi M; Oelze M; Dragoni S; Liuni A; Steven S; Luca MC; Stalleicken D; Münzel T; Laghi-Pasini F; Daiber A; Parker JD; Gori T
    Clin Res Cardiol; 2012 Jun; 101(6):453-9. PubMed ID: 22298019
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Comparative evaluation of the clinical effectiveness and the adverse effects of three different forms of nitrates in high oral doses in patients with stable angina pectoris].
    Kośmicki M; Kowalik I; Jedrzejczyk B; Sadowski Z
    Pol Arch Med Wewn; 2002 Jun; 107(6):509-17. PubMed ID: 12371383
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Nitrates. The place in contemporary therapy of ischemic heart disease].
    Martsevich SIu
    Kardiologiia; 2005; 45(7):69-72. PubMed ID: 16091666
    [No Abstract]   [Full Text] [Related]  

  • 26. Nitrates: why and how should they be used today? Current status of the clinical usefulness of nitroglycerin, isosorbide dinitrate and isosorbide-5-mononitrate.
    Silber S
    Eur J Clin Pharmacol; 1990; 38 Suppl 1():S35-51. PubMed ID: 2113003
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Organic nitrates: update on mechanisms underlying vasodilation, tolerance and endothelial dysfunction.
    Münzel T; Steven S; Daiber A
    Vascul Pharmacol; 2014 Dec; 63(3):105-13. PubMed ID: 25446162
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Potency and in vitro tolerance of organic nitrates: partially denitrated metabolites contribute to the tolerance-devoid activity of pentaerythrityl tetranitrate.
    Koenig A; Lange K; Konter J; Daiber A; Stalleicken D; Glusa E; Lehmann J
    J Cardiovasc Pharmacol; 2007 Jul; 50(1):68-74. PubMed ID: 17666918
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mechanisms of action of nitrates.
    Torfgård KE; Ahlner J
    Cardiovasc Drugs Ther; 1994 Oct; 8(5):701-17. PubMed ID: 7873467
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparative vasodilator effects of nitroglycerin, pentaerythritol trinitrate and biometabolites, and other organic nitrates.
    Parker JC; Di Carlo FJ; Davidson IW
    Eur J Pharmacol; 1975 Mar; 31(1):29-37. PubMed ID: 805053
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Continuous protection against angina pectoris-like disorders. Attack prevention without a nitrate pause].
    MMW Fortschr Med; 2003 Sep; 145(39):54. PubMed ID: 14649081
    [No Abstract]   [Full Text] [Related]  

  • 32. Pharmacologic and biochemical evaluation of organic nitrates: attempted correlation of activities.
    Blum SW; Quinn JB; Howe BB; Hefner MA; Winbury MM
    J Pharmacol Exp Ther; 1971 Mar; 176(3):684-91. PubMed ID: 4329454
    [No Abstract]   [Full Text] [Related]  

  • 33. Nitrate tolerance as a model of vascular dysfunction: roles for mitochondrial aldehyde dehydrogenase and mitochondrial oxidative stress.
    Daiber A; Oelze M; Wenzel P; Wickramanayake JM; Schuhmacher S; Jansen T; Lackner KJ; Torzewski M; Münzel T
    Pharmacol Rep; 2009; 61(1):33-48. PubMed ID: 19307691
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-acting nitrates in the treatment of angina pectoris.
    Reichek N
    JAMA; 1976 Sep; 236(12):1399-402. PubMed ID: 822177
    [No Abstract]   [Full Text] [Related]  

  • 35. The rationale for nitrates in angina pectoris.
    Held P; Olsson G
    Can J Cardiol; 1995 Apr; 11 Suppl B():11B-13B. PubMed ID: 7728648
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Organic nitrates and nitrate resistance in diabetes: the role of vascular dysfunction and oxidative stress with emphasis on antioxidant properties of pentaerithrityl tetranitrate.
    Oelze M; Schuhmacher S; Daiber A
    Exp Diabetes Res; 2010; 2010():213176. PubMed ID: 21234399
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Number of nitrate groups determines reactivity and potency of organic nitrates: a proof of concept study in ALDH-2-/- mice.
    Wenzel P; Hink U; Oelze M; Seeling A; Isse T; Bruns K; Steinhoff L; Brandt M; Kleschyov AL; Schulz E; Lange K; Weiner H; Lehmann J; Lackner KJ; Kawamoto T; Münzel T; Daiber A
    Br J Pharmacol; 2007 Feb; 150(4):526-33. PubMed ID: 17220910
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Role of nitrates in the treatment of ischemia].
    Schwinger RH
    Dtsch Med Wochenschr; 2000 Apr; 125 Suppl 1():S6. PubMed ID: 10818994
    [No Abstract]   [Full Text] [Related]  

  • 39. Differential effects of pentaerythritol tetranitrate and nitroglycerin on the development of tolerance and evidence of lipid peroxidation: a human in vivo study.
    Jurt U; Gori T; Ravandi A; Babaei S; Zeman P; Parker JD
    J Am Coll Cardiol; 2001 Sep; 38(3):854-9. PubMed ID: 11527645
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Use of nitrates in ischemic heart disease.
    Giuseppe C; Paul J; Hans-Ulrich I
    Expert Opin Pharmacother; 2015; 16(11):1567-72. PubMed ID: 26027641
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.